These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014 [TBL] [Abstract][Full Text] [Related]
25. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells. Schaper K; Kietzmann M; Bäumer W Mol Immunol; 2014 May; 59(1):10-8. PubMed ID: 24434636 [TBL] [Abstract][Full Text] [Related]
26. Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss. Weske S; Vaidya M; Reese A; von Wnuck Lipinski K; Keul P; Bayer JK; Fischer JW; Flögel U; Nelsen J; Epple M; Scatena M; Schwedhelm E; Dörr M; Völzke H; Moritz E; Hannemann A; Rauch BH; Gräler MH; Heusch G; Levkau B Nat Med; 2018 May; 24(5):667-678. PubMed ID: 29662200 [TBL] [Abstract][Full Text] [Related]
27. Ichthyosis linked to sphingosine 1-phosphate lyase insufficiency is due to aberrant sphingolipid and calcium regulation. Smith CJ; Williams JL; Hall C; Casas J; Caley MP; O'Toole EA; Prasad R; Metherell LA J Lipid Res; 2023 Apr; 64(4):100351. PubMed ID: 36868360 [TBL] [Abstract][Full Text] [Related]
28. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. Schüppel M; Kürschner U; Kleuser U; Schäfer-Korting M; Kleuser B J Invest Dermatol; 2008 Jul; 128(7):1747-56. PubMed ID: 18219276 [TBL] [Abstract][Full Text] [Related]
29. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. Thatikonda S; Pooladanda V; Sigalapalli DK; Godugu C Cell Death Dis; 2020 Jan; 11(1):21. PubMed ID: 31924750 [TBL] [Abstract][Full Text] [Related]
31. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. Ihlefeld K; Claas RF; Koch A; Pfeilschifter JM; Meyer Zu Heringdorf D Biochem J; 2012 Nov; 447(3):457-64. PubMed ID: 22908849 [TBL] [Abstract][Full Text] [Related]
32. First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells. Engel N; Adamus A; Frank M; Kraft K; Kühn J; Müller P; Nebe B; Kasten A; Seitz G PLoS One; 2018; 13(5):e0196854. PubMed ID: 29718989 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Venkataraman K; Lee YM; Michaud J; Thangada S; Ai Y; Bonkovsky HL; Parikh NS; Habrukowich C; Hla T Circ Res; 2008 Mar; 102(6):669-76. PubMed ID: 18258856 [TBL] [Abstract][Full Text] [Related]
35. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins. Harijith A; Pendyala S; Reddy NM; Bai T; Usatyuk PV; Berdyshev E; Gorshkova I; Huang LS; Mohan V; Garzon S; Kanteti P; Reddy SP; Raj JU; Natarajan V Am J Pathol; 2013 Oct; 183(4):1169-1182. PubMed ID: 23933064 [TBL] [Abstract][Full Text] [Related]
36. S1P Lyase siRNA Dampens Malignancy of DLD-1 Colorectal Cancer Cells. Faqar-Uz-Zaman WF; Schmidt KG; Thomas D; Pfeilschifter JM; Radeke HH; Schwiebs A Lipids; 2021 Mar; 56(2):155-166. PubMed ID: 32971566 [TBL] [Abstract][Full Text] [Related]
37. Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. Bektas M; Allende ML; Lee BG; Chen W; Amar MJ; Remaley AT; Saba JD; Proia RL J Biol Chem; 2010 Apr; 285(14):10880-9. PubMed ID: 20097939 [TBL] [Abstract][Full Text] [Related]
38. Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. Allende ML; Bektas M; Lee BG; Bonifacino E; Kang J; Tuymetova G; Chen W; Saba JD; Proia RL J Biol Chem; 2011 Mar; 286(9):7348-58. PubMed ID: 21173151 [TBL] [Abstract][Full Text] [Related]
39. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931. Veltman M; Stolarczyk M; Radzioch D; Wojewodka G; De Sanctis JB; Dik WA; Dzyubachyk O; Oravecz T; de Kleer I; Scholte BJ Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L1000-L1014. PubMed ID: 27663991 [TBL] [Abstract][Full Text] [Related]
40. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. Bot M; Van Veldhoven PP; de Jager SC; Johnson J; Nijstad N; Van Santbrink PJ; Westra MM; Van Der Hoeven G; Gijbels MJ; Müller-Tidow C; Varga G; Tietge UJ; Kuiper J; Van Berkel TJ; Nofer JR; Bot I; Biessen EA PLoS One; 2013; 8(5):e63360. PubMed ID: 23700419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]